First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.

Thomas BardolZahra Eslami-SDoryan MasmoudiMarie AlexandreMarie Duboys de LabarreAngélique BobrieVéronique D'HondtSéverine GuiuKeerthi KurmaLaure CayrefourcqWilliam JacotCatherine Alix-Panabières

Published in: Cancer medicine (2023)

CTC assay is a promising tool that can be used for liquid biopsy in future clinical trials to stratify and monitor patients with cancer receiving anti-AXL therapies.

Keyphrases

circulating tumor cells
tyrosine kinase
clinical trial
poor prognosis
circulating tumor
squamous cell carcinoma
small cell lung cancer
current status
high throughput
ultrasound guided
fine needle aspiration
ionic liquid
binding protein
randomized controlled trial
open label
cell free